Literature DB >> 8213054

Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance.

K Hestad1, J H McArthur, G J Dal Pan, O A Selnes, T E Nance-Sproson, E Aylward, V P Mathews, J C McArthur.   

Abstract

Quantified magnetic resonance imaging (MRI) was related to neuropsychological (NP) test scores in an asymptomatic HIV-1 seropositive group, a non-demented AIDS/ARC group, a group of subjects with HIV-1 dementia, and a seronegative control group. The MRIs were quantified using three planimetric measures of brain structure: the bicaudate ratio (a measure of caudate region atrophy), the bifrontal ratio (a measure of frontal region atrophy), and the ventricle to brain ratio (a measure of overall cerebral atrophy). Cognitive performance was assessed with standard NP tests. Significant correlations between the MRI ratios and many of the NP tests were observed. Of the tests grooved pegboard, part B of the trail making test, the verbal fluency test, and the digit span forward were associated with MRI abnormalities. The bicaudate ratio was most closely associated with the NP tests. These findings indicate that ventricular enlargement, especially in the region of the caudate, is closely related to poor NP test performance in HIV-1 infection.

Entities:  

Mesh:

Year:  1993        PMID: 8213054     DOI: 10.1111/j.1600-0404.1993.tb04201.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  40 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

Review 2.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

4.  Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.

Authors:  V A Cardenas; D J Meyerhoff; C Studholme; J Kornak; J Rothlind; H Lampiris; J Neuhaus; R M Grant; L L Chao; D Truran; M W Weiner
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

5.  Quantitative MRI Measures in SIV-Infected Macaque Brains.

Authors:  Xiaodong Zhang; Chunxia Li
Journal:  J Clin Cell Immunol       Date:  2013

6.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

Review 7.  Separate digits tests: a brief history, a literature review, and a reexamination of the factor structure of the Test of Memory and Learning (TOMAL).

Authors:  M C Ramsay; C R Reynolds
Journal:  Neuropsychol Rev       Date:  1995-09       Impact factor: 7.444

8.  HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.

Authors:  Beau M Ances; David B Clifford
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

9.  Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.

Authors:  James P Kesby; David T Hubbard; Athina Markou; Svetlana Semenova
Journal:  Addict Biol       Date:  2012-12-18       Impact factor: 4.280

Review 10.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.